about
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureusRNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infectionEfficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected WoundRNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells.Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection.Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat modelEfficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.LL-37 protects rats against lethal sepsis caused by gram-negative bacteriaInteraction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureusA chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococciWhy tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E.Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic RatsTemporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptidesThe efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infectionIdentification and characterization of cancer stem cells from head and neck squamous cell carcinoma cell lines.Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice.In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging.Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis.S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis.Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells.Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.Enhanced Efficacy of Combinations of Pexiganan with Colistin Versus Acinetobacter Baumannii in Experimental Sepsis.Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureusRNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formationEfficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus.Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection.In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.In vivo effect of alpha-bisabolol, a nontoxic sesquiterpene alcohol, on the induction of spontaneous mammary tumors in HER-2/neu transgenic mice.
P50
Q24643367-47111B81-F191-40E5-9089-D90C178E2F31Q24682401-D6A16D29-8AF3-451D-A5FB-8072A0C9D347Q28552608-A926416D-48F1-4B68-8557-FEF24DE97477Q31131231-F6975913-44C6-49C0-9849-3E2DB9B3B3DDQ33980808-6BCC3990-AE6D-45E0-8D04-FD6D437FF25DQ34104726-5774846D-32D7-45CE-93DB-CA162202A08EQ34113126-C9F4CE5C-A676-409E-BE77-69FE02A16934Q34648782-E874D928-CABB-4AE2-A260-9B3C9464E840Q34721515-69C0086F-0D22-4AA4-9D75-7829B01BCD1BQ35013893-127CB8AE-F54F-49C8-BE46-185304D9F620Q35124472-25A0EEAC-CD72-4418-B9E9-8AAB4827113FQ35648953-14F67BB1-B4B9-496F-ACBF-2375ABA95774Q35806170-3F6E5853-C7E4-46AF-A0EB-589733A3CDDAQ35945879-9118FF08-6438-401C-81BB-38D8C304B6D8Q36669700-36C0D405-B97C-4D72-95BC-7E7A4A357645Q37139168-B65533B9-146E-4EB7-8F55-3D52F19BCB53Q38869993-50A381A4-266E-4384-B899-EF1049D0F5C5Q38899363-593447C5-8703-467F-84A3-3EAD87EB796DQ39190482-EA389A16-D04E-4DB5-BA08-EC2306A63B5EQ39472952-12817FE7-BCB5-4C7F-8C78-6791B0288CEBQ39773341-6BF82EE7-853B-4AF6-8A19-C4E3AA7A5AA0Q39790451-C3791EE1-8138-4B11-A8EE-8CFDBFBF27BFQ40045932-A33D5231-D3BD-4280-85DE-CD827C33D277Q40243056-64624DF8-CDFB-4DF5-8D52-4C78C4237ECAQ40313006-8389C2CD-6153-47A2-9D91-7586444EF8A2Q40405399-D7EBF51B-8B13-4EE2-B420-D9CFF02873D6Q40457245-00BE4FBB-AD52-42E8-8FF1-7F3B2075AEFAQ40462433-46E1B3DC-607E-4CD7-AC9A-1A6CC45A08D0Q40803400-CFE87A17-23BA-4312-A673-BF9170E24AB9Q41389990-1A6984CE-0C4D-4C1D-A88D-B115926B23F2Q41865746-EF10E36B-FCF9-4C46-BF5D-615123F90BFBQ41966050-C1E79DFB-ECE1-4C39-B062-80B31DAD1C4BQ42021167-FF944EC6-E0EC-4F30-A895-3F90F30512FEQ42228223-17FB5792-44E3-49DE-900F-90871C0B988CQ42244876-881CFB1A-4AB0-493A-ACC5-56594A0C79F2Q42256899-3FBA8EF2-3B69-42FB-8A93-C54D56E8C511Q42545764-E586A374-914D-4470-9647-E59EA183AB1CQ42876968-B19A136B-6003-41E4-86DA-11618A30839BQ42953410-0A6FF5E7-94F4-4207-8A2F-FC0EE14E68EFQ43044415-307DD65C-11BB-4AF3-8F66-5BB547EEAB85
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fiorenza Orlando
@ast
Fiorenza Orlando
@en
Fiorenza Orlando
@es
Fiorenza Orlando
@nl
Fiorenza Orlando
@sl
type
label
Fiorenza Orlando
@ast
Fiorenza Orlando
@en
Fiorenza Orlando
@es
Fiorenza Orlando
@nl
Fiorenza Orlando
@sl
prefLabel
Fiorenza Orlando
@ast
Fiorenza Orlando
@en
Fiorenza Orlando
@es
Fiorenza Orlando
@nl
Fiorenza Orlando
@sl
P106
P1153
7003327070
P21
P31
P496
0000-0001-7351-4430